Search Within

Karen Anne Autio

Formats
  1. Meeting Abstract (77)
  2. Journal Article (41)
  3. Review (3)
Groups
  1. Department of Medicine (121)
  2. Genitourinary Oncology Service (121)
  3. Solid Tumor Oncology Division (121)
  4. Hematologic Malignancies, Division of (30)
  5. GSK Faculty (21)
  6. Epidemiology and Biostatistics (14)

More Groups

People
  1. Howard Scher (47)
  2. Michael Morris (36)
  3. Dana Rathkopf (34)
  4. Susan Slovin (28)
  5. Daniel Danila (23)
  6. Wassim Abida (15)

More People

Years
  1. 2025 (6)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Annals of Oncology (18)
  3. Journal for ImmunoTherapy of Cancer (11)
  4. Clinical Cancer Research (8)
  5. Journal of Immunotherapy and Precision Oncology (3)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Oxford University Press (18)
  3. Biomed Central Ltd (11)
  4. American Association for Cancer Research (10)
  5. Elsevier Inc. (5)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (121)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8(+) T cell invigoration and polyclonal T cell expansion in cancer patients
    Journal Article

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Chan, I. H.; Shen, C.; Ratti, N. P.; Rojo, B.; Autio, K. A.; Wong, D. J.; Patel, M. R.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: A phase 2 clinical trial
    Journal Article

    Autio, K. A.; Dreicer, R.; Anderson, J.; Garcia, J. A.; Alva, A.; Hart, L. L.; Milowsky, M. I.; Posadas, E. M.; Ryan, C. J.; Graf, R. P.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC
    Meeting Abstract

    Wong, D. J. L.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Infante, J. R.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; Gabrail, N. Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I study with pegylated human IL-10 (AM0010) alone or in combination with anti-PD-1 or FOLFOX-immune biomarker update
    Meeting Abstract

    Naing, A.; Infante, J. R.; Hecht, J. R.; Papadopoulos, K. P.; Wong, D. J. L.; Autio, K. A.; Falchook, G. S.; Patel, M. R.; Ott, P. A.; Patnaik, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of pegylated human IL-10 (AM0010) in combination with an anti-PD-1 in renal cell cancer
    Meeting Abstract

    Naing, A.; Infante, J. R.; Wong, D. J. L.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K. P.; Autio, K. A.; Pant, S.; Bauer, T. M.; Drakaki, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1b study with PEGylated human IL-10 (AM0010) with 5-FU and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy of PEGylated human IL-10 (AM0010) in combination with anti-PD-1 blockade in patients (pts) with metastatic renal cell carcinoma (mRCC): A phase 1b trial
    Meeting Abstract

    Naing, A.; Infante, J.; Wong, D.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K.; Autio, K.; Pant, S.; Bauer, T.; Drakaki, A.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • PEGylated human IL-10 (AM0010) in combination with an anti-PD-1 in advanced NSCLC
    Meeting Abstract

    Wong, D.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Infante, J.; Patel, M.; Autio, K.; Papadopoulos, K.; Naing, A.; Gabrail, N. Y.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy and immune activation with PEGylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC: Update
    Meeting Abstract

    Wong, D. J.; Schneider, J. G.; Aljumaily, R.; Korn, M. W.; Autio, K.; Infante, J. R.; Patel, M. R.; Papadopoulos, K.; Naing, A.; Gabrail, N.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save